Graybug Vision Inc (GRAY): Price and Financial Metrics Recent IPO

Graybug Vision Inc (GRAY) Recent IPO

Today's Latest Price: $24.84 USD

9.09 (-26.79%)

Updated Nov 24 7:56pm

Add GRAY to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

GRAY Stock Price Chart Interactive Chart >

Price chart for GRAY

GRAY Price/Volume Stats

Current price $24.84 52-week high $37.88
Prev. close $33.93 52-week low $12.50
Day low $23.81 Volume 273,500
Day high $34.76 Avg. volume 133,079
50-day MA $0.00 Dividend yield N/A
200-day MA $0.00 Market Cap 521.12M

Graybug Vision Inc (GRAY) Company Bio

GrayBug is a pharmaceutical company that focuses on developing the next generation of products for the treatment of chronic vision-threatening diseases of the retina and optic nerve. The company is currently developing a continuum of proprietary micro – and nanoparticle controlled release technologies and implants for strategic partnership and its own therapeutic products for major ocular disease indications including wet AMD and Glaucoma. The company was founded in 2011 and headquartered in Baltimore, Maryland.

GRAY Latest News Stream

Event/Time News Detail
Loading, please wait...

GRAY Latest Social Stream

Loading social stream, please wait...

View Full GRAY Social Stream

Latest GRAY News From Around the Web

Below are the latest news stories about Graybug Vision Inc that investors may wish to consider to help them evaluate GRAY as an investment opportunity.

Graybug Vision opens 18.8% above the IPO price

Graybug Vision (GRAY) opens at $19 after pricing IPO at $16, in line of the prior expected range of $15-$17.At the IPO price, the company raised $90M and was valued at $306.5M.Previously: Graybug Vision prices upsized IPO at $16, in line with the expected range (Sept. 25)...

Seeking Alpha | September 25, 2020

Graybug Vision Readies $75 Million IPO Effort

Quick Take Graybug Vision (GRAY) has filed to raise $75 million in an IPO of its common stock, according to an S-1 registration statement. The company is developing treatments for diseases of the retina and optic nerve. GRAY has achieved impressive Phase 2b trial results, and the IPO appears reasonably...

Donovan Jones on Seeking Alpha | September 22, 2020

Read More 'GRAY' Stories Here

GRAY Price Returns

1-mo 66.15%
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.5983 seconds.